Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jennifer Kiser

Concepts (358)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
32
2025
736
6.180
 Why?
Anti-HIV Agents
35
2025
772
4.500
 Why?
HIV Infections
56
2025
2812
4.300
 Why?
Adenine
29
2025
267
4.150
 Why?
Hepatitis C
13
2023
263
4.140
 Why?
Hepatitis C, Chronic
14
2025
163
3.930
 Why?
Ribavirin
15
2020
91
3.760
 Why?
Sofosbuvir
13
2025
59
3.690
 Why?
Drug Interactions
21
2019
405
3.280
 Why?
Tenofovir
30
2025
240
3.220
 Why?
Tandem Mass Spectrometry
17
2025
532
2.290
 Why?
Hepacivirus
11
2025
258
1.940
 Why?
Dried Blood Spot Testing
13
2024
103
1.880
 Why?
Proline
5
2019
79
1.850
 Why?
Organophosphates
15
2025
134
1.760
 Why?
Oligopeptides
8
2015
272
1.760
 Why?
Emtricitabine
19
2025
174
1.730
 Why?
Organophosphonates
12
2014
92
1.570
 Why?
Ritonavir
8
2021
73
1.440
 Why?
Protease Inhibitors
4
2020
106
1.390
 Why?
Coinfection
5
2024
136
1.290
 Why?
Chromatography, Liquid
14
2025
432
1.290
 Why?
Benzimidazoles
6
2025
168
1.220
 Why?
Phosphorous Acids
3
2019
12
1.190
 Why?
Fluorenes
4
2020
42
1.090
 Why?
Pyrophosphatases
3
2016
28
1.070
 Why?
Hepatitis B
4
2024
70
1.050
 Why?
Nucleotides
3
2016
124
1.050
 Why?
Anti-Retroviral Agents
5
2019
232
0.940
 Why?
Drug Therapy, Combination
12
2018
1059
0.860
 Why?
Pyridines
5
2015
505
0.820
 Why?
Polyphosphates
7
2022
36
0.770
 Why?
Erythrocytes
8
2016
692
0.760
 Why?
Humans
101
2025
136783
0.750
 Why?
Cell Phone
1
2022
75
0.750
 Why?
Reverse Transcriptase Inhibitors
5
2014
84
0.740
 Why?
HIV Protease Inhibitors
5
2011
69
0.740
 Why?
Viral Load
11
2024
460
0.720
 Why?
Membrane Transport Proteins
4
2016
162
0.710
 Why?
Simeprevir
2
2018
9
0.710
 Why?
HIV-1
7
2021
857
0.700
 Why?
Sulfonamides
5
2019
512
0.690
 Why?
Mobile Applications
1
2022
180
0.650
 Why?
Therapies, Investigational
1
2019
17
0.650
 Why?
Medication Adherence
12
2022
468
0.630
 Why?
Heterocyclic Compounds, 3-Ring
2
2023
32
0.620
 Why?
Respiratory Syncytial Virus Infections
1
2020
128
0.610
 Why?
Leukocytes, Mononuclear
9
2025
556
0.590
 Why?
Ethanol
1
2023
608
0.590
 Why?
Adult
45
2025
37616
0.580
 Why?
Male
55
2025
67361
0.570
 Why?
Antiretroviral Therapy, Highly Active
4
2015
269
0.570
 Why?
Pyridazines
2
2021
56
0.570
 Why?
Middle Aged
39
2025
33200
0.560
 Why?
Solid Phase Extraction
2
2014
25
0.550
 Why?
Lung Transplantation
1
2020
308
0.550
 Why?
Pyrimidinones
2
2008
113
0.530
 Why?
HIV Integrase Inhibitors
1
2018
70
0.530
 Why?
Inosine
1
2016
14
0.520
 Why?
Liver
2
2016
1938
0.520
 Why?
Guanosine
1
2016
41
0.520
 Why?
Pharmacogenomic Variants
1
2016
35
0.510
 Why?
Purines
1
2016
176
0.480
 Why?
Female
50
2025
72840
0.480
 Why?
Carbamates
2
2025
49
0.480
 Why?
Chromatography, High Pressure Liquid
2
2015
591
0.480
 Why?
Drug Discovery
1
2016
141
0.470
 Why?
Drug Monitoring
3
2022
219
0.470
 Why?
Isoniazid
2
2012
63
0.470
 Why?
Serum
1
2015
59
0.460
 Why?
Adenosine
1
2016
226
0.460
 Why?
Intracellular Space
1
2014
68
0.450
 Why?
Kidney
4
2016
1463
0.440
 Why?
Pre-Exposure Prophylaxis
5
2020
213
0.430
 Why?
HIV
4
2019
233
0.430
 Why?
Receptors, Adrenergic, alpha
1
2013
26
0.430
 Why?
Priapism
1
2013
11
0.430
 Why?
Adrenergic alpha-Antagonists
1
2013
34
0.430
 Why?
Telemedicine
1
2022
847
0.420
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.420
 Why?
Antitubercular Agents
2
2012
203
0.420
 Why?
Deoxycytidine
6
2017
175
0.420
 Why?
Hepatitis B, Chronic
3
2022
23
0.390
 Why?
Hepatitis B virus
4
2024
40
0.390
 Why?
Gastric Bypass
1
2014
118
0.390
 Why?
Treatment Outcome
13
2025
10764
0.380
 Why?
Alanine
5
2025
151
0.360
 Why?
Phenotype
2
2016
3199
0.350
 Why?
Prospective Studies
17
2022
7583
0.350
 Why?
HIV Seronegativity
1
2010
28
0.350
 Why?
Antacids
1
2010
16
0.350
 Why?
Pyrrolidinones
1
2010
29
0.340
 Why?
Genotype
6
2023
1919
0.340
 Why?
Pyrimidines
3
2021
470
0.340
 Why?
Patient Compliance
3
2017
576
0.330
 Why?
Tuberculosis
2
2012
279
0.330
 Why?
Pharmacy Service, Hospital
1
2011
90
0.330
 Why?
Blood Chemical Analysis
4
2019
99
0.320
 Why?
Plasma
4
2016
213
0.320
 Why?
Area Under Curve
4
2018
313
0.320
 Why?
Pregnancy Complications, Infectious
3
2025
389
0.310
 Why?
Reproducibility of Results
8
2016
3272
0.310
 Why?
Uridine Monophosphate
2
2019
15
0.310
 Why?
Drug Prescriptions
1
2011
247
0.300
 Why?
Fluorobenzenes
1
2008
16
0.290
 Why?
Young Adult
17
2025
13126
0.290
 Why?
Drug Stability
5
2016
166
0.280
 Why?
Adolescent
20
2020
21463
0.280
 Why?
Guidelines as Topic
1
2009
276
0.270
 Why?
Atazanavir Sulfate
5
2015
41
0.270
 Why?
Liver Transplantation
1
2014
871
0.260
 Why?
Sensitivity and Specificity
5
2014
1942
0.260
 Why?
Half-Life
3
2015
165
0.260
 Why?
Esomeprazole
1
2006
7
0.250
 Why?
Anti-Ulcer Agents
1
2006
16
0.250
 Why?
Glycerophospholipids
2
2023
34
0.250
 Why?
Pharmacology, Clinical
1
2006
9
0.250
 Why?
Sustained Virologic Response
3
2023
40
0.250
 Why?
Hepatocytes
3
2016
220
0.240
 Why?
Education
1
2006
106
0.240
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2025
20
0.240
 Why?
Proton Pump Inhibitors
1
2006
108
0.230
 Why?
South Africa
4
2015
219
0.230
 Why?
Phosphates
3
2015
183
0.220
 Why?
Anemia
2
2016
170
0.220
 Why?
Biomarkers
5
2023
4158
0.210
 Why?
Variola virus
1
2022
2
0.200
 Why?
Smallpox
1
2022
8
0.200
 Why?
Health Personnel
1
2009
698
0.200
 Why?
World Health Organization
1
2022
122
0.190
 Why?
Delivery of Health Care
1
2009
939
0.190
 Why?
Linear Models
2
2014
845
0.180
 Why?
Cyclopropanes
2
2019
90
0.180
 Why?
Blood Platelets
1
2025
405
0.180
 Why?
Cross-Over Studies
4
2020
560
0.180
 Why?
Lopinavir
3
2020
30
0.180
 Why?
Dideoxynucleosides
2
2023
21
0.180
 Why?
Point-of-Care Systems
1
2023
163
0.180
 Why?
Phosphorylation
2
2015
1756
0.170
 Why?
Interferons
2
2019
199
0.170
 Why?
Aminoisobutyric Acids
1
2019
7
0.160
 Why?
Drug Administration Schedule
3
2019
783
0.160
 Why?
Lactams, Macrocyclic
1
2019
49
0.160
 Why?
Homosexuality, Male
2
2017
182
0.160
 Why?
Neutrophils
1
2025
1234
0.160
 Why?
Pyrrolidines
1
2019
80
0.160
 Why?
Quinoxalines
1
2019
66
0.160
 Why?
Leucine
1
2019
111
0.150
 Why?
Nucleic Acids
1
2019
71
0.150
 Why?
Quality Control
2
2015
171
0.140
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.140
 Why?
Oxazines
1
2018
30
0.140
 Why?
Multidrug Resistance-Associated Proteins
2
2008
38
0.140
 Why?
Directly Observed Therapy
1
2017
15
0.140
 Why?
Bronchoalveolar Lavage Fluid
1
2020
654
0.140
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
19
0.140
 Why?
Nitriles
2
2021
172
0.140
 Why?
Pregnancy Outcome
1
2020
409
0.140
 Why?
Pharmacogenetics
2
2016
179
0.130
 Why?
Inosine Triphosphate
1
2016
2
0.130
 Why?
Liver Cirrhosis
1
2019
316
0.130
 Why?
Anemia, Hemolytic
1
2016
20
0.130
 Why?
Darunavir
2
2014
18
0.130
 Why?
Deoxyadenine Nucleotides
1
2016
14
0.130
 Why?
Deoxycytosine Nucleotides
1
2016
11
0.130
 Why?
Glass
1
2016
43
0.130
 Why?
Guanosine Triphosphate
1
2016
91
0.130
 Why?
Drug Combinations
3
2025
344
0.130
 Why?
Pharmacy
1
2017
32
0.130
 Why?
Molecular Targeted Therapy
1
2019
413
0.130
 Why?
Genitalia
1
2016
30
0.130
 Why?
Syringes
1
2016
42
0.130
 Why?
Disease Transmission, Infectious
1
2017
61
0.130
 Why?
Drug Packaging
1
2016
41
0.130
 Why?
Drug and Narcotic Control
1
2016
28
0.130
 Why?
Viremia
3
2022
138
0.130
 Why?
Pyridones
1
2018
168
0.130
 Why?
Zika Virus
1
2017
125
0.120
 Why?
Fibroblast Growth Factors
2
2014
171
0.120
 Why?
Polymers
1
2019
491
0.120
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
442
0.120
 Why?
Biological Assay
1
2016
123
0.120
 Why?
Piperazines
1
2018
350
0.120
 Why?
Cytosol
1
2016
226
0.120
 Why?
Practice Guidelines as Topic
2
2016
1568
0.120
 Why?
Polymorphism, Single Nucleotide
2
2016
2190
0.120
 Why?
Creatinine
2
2018
498
0.120
 Why?
Retrospective Studies
4
2020
15564
0.120
 Why?
Brain Diseases
1
2016
141
0.120
 Why?
Population
1
2015
35
0.120
 Why?
Rectum
1
2016
185
0.120
 Why?
Nonlinear Dynamics
1
2015
87
0.120
 Why?
Analgesics
1
2017
205
0.120
 Why?
Chemical and Drug Induced Liver Injury
1
2016
136
0.120
 Why?
Mental Health Services
1
2019
414
0.110
 Why?
Liver Function Tests
1
2015
114
0.110
 Why?
CD4 Lymphocyte Count
2
2015
267
0.110
 Why?
Virus Replication
1
2017
479
0.110
 Why?
Pharmacists
1
2017
260
0.110
 Why?
Pharmaceutical Preparations
1
2016
179
0.110
 Why?
Adenosine Triphosphate
1
2016
486
0.110
 Why?
Least-Squares Analysis
1
2014
78
0.110
 Why?
Administration, Oral
3
2019
808
0.110
 Why?
Infectious Disease Transmission, Vertical
3
2025
182
0.110
 Why?
Metabolic Clearance Rate
2
2018
116
0.110
 Why?
Cholecalciferol
1
2014
60
0.110
 Why?
Infant
5
2020
9442
0.110
 Why?
Hypophosphatemia
1
2013
17
0.110
 Why?
Double-Blind Method
3
2013
1981
0.100
 Why?
Diphosphates
3
2021
17
0.100
 Why?
Calcitriol
1
2013
58
0.100
 Why?
Liver Diseases
1
2016
311
0.100
 Why?
Tablets
2
2023
36
0.100
 Why?
Cytochrome P-450 CYP3A
1
2013
88
0.100
 Why?
Leukocytes
1
2014
312
0.100
 Why?
Desiccation
1
2012
19
0.100
 Why?
Monocytes
1
2015
561
0.100
 Why?
Case-Control Studies
3
2024
3537
0.100
 Why?
Kidney Diseases
1
2016
406
0.100
 Why?
Benzoxazines
1
2012
31
0.090
 Why?
Organic Anion Transporters
1
2011
12
0.090
 Why?
Diabetes Mellitus
1
2020
1033
0.090
 Why?
Levonorgestrel
1
2012
38
0.090
 Why?
Pravastatin
1
2011
41
0.090
 Why?
Arylamine N-Acetyltransferase
1
2011
6
0.090
 Why?
Benchmarking
2
2024
183
0.090
 Why?
Nucleosides
1
2011
27
0.090
 Why?
Interferon-alpha
1
2012
198
0.090
 Why?
Vitamin D Deficiency
1
2013
184
0.090
 Why?
Child, Preschool
4
2021
11069
0.090
 Why?
Specimen Handling
1
2012
178
0.090
 Why?
Mental Disorders
1
2019
1075
0.090
 Why?
Contraceptive Agents, Female
1
2012
80
0.090
 Why?
Raltegravir Potassium
1
2010
17
0.090
 Why?
Models, Statistical
1
2015
658
0.090
 Why?
Hospitals, University
1
2011
180
0.090
 Why?
Body Weight
1
2015
981
0.080
 Why?
Patient Acceptance of Health Care
1
2017
806
0.080
 Why?
Sex Distribution
1
2011
376
0.080
 Why?
Cohort Studies
2
2019
5718
0.080
 Why?
Sex Characteristics
1
2015
763
0.080
 Why?
Dietary Supplements
1
2014
559
0.080
 Why?
Aged
5
2018
23729
0.080
 Why?
Mycobacterium tuberculosis
1
2012
312
0.080
 Why?
Time Factors
4
2016
6792
0.070
 Why?
Lamivudine
2
2023
63
0.070
 Why?
Rosuvastatin Calcium
1
2008
22
0.070
 Why?
Pregnancy
4
2025
6731
0.070
 Why?
Immunosuppressive Agents
1
2012
890
0.070
 Why?
Kidney Calculi
1
2007
37
0.070
 Why?
Portugal
1
2006
10
0.070
 Why?
Gene Frequency
1
2008
520
0.070
 Why?
Quebec
1
2006
11
0.060
 Why?
Furans
1
2006
24
0.060
 Why?
Education, Medical
1
2009
260
0.060
 Why?
Self Report
2
2021
825
0.060
 Why?
Dementia
1
2009
252
0.060
 Why?
Benzopyrans
1
2025
26
0.060
 Why?
Referral and Consultation
1
2011
777
0.060
 Why?
Internationality
1
2006
155
0.060
 Why?
Sexual and Gender Minorities
2
2019
213
0.060
 Why?
Hematocrit
2
2016
95
0.060
 Why?
United States
4
2017
14660
0.060
 Why?
Child
4
2021
21968
0.060
 Why?
Predictive Value of Tests
2
2019
2030
0.050
 Why?
Lipids
1
2008
665
0.050
 Why?
Isoindoles
1
2022
4
0.050
 Why?
Monkeypox virus
1
2022
16
0.050
 Why?
Risk Assessment
1
2012
3429
0.050
 Why?
Calibration
2
2013
145
0.050
 Why?
Demography
1
2022
291
0.050
 Why?
Treatment Failure
1
2023
353
0.050
 Why?
Computer Simulation
2
2016
973
0.050
 Why?
Benzamides
1
2022
217
0.050
 Why?
Temperature
2
2016
674
0.050
 Why?
Animals
4
2022
36768
0.050
 Why?
Drug Approval
1
2020
87
0.040
 Why?
Tissue Donors
1
2023
417
0.040
 Why?
Lactation
1
2020
181
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
2045
0.040
 Why?
Models, Biological
2
2016
1769
0.040
 Why?
Developing Countries
1
2020
306
0.040
 Why?
Chemistry Techniques, Analytical
1
2018
21
0.040
 Why?
Flaviviridae
1
2017
7
0.030
 Why?
Vero Cells
1
2017
67
0.030
 Why?
Inhibitory Concentration 50
1
2017
90
0.030
 Why?
A549 Cells
1
2017
65
0.030
 Why?
Drug Repositioning
1
2017
35
0.030
 Why?
Hair
1
2018
84
0.030
 Why?
Pharmaceutical Solutions
1
2016
14
0.030
 Why?
Chromatography, Reverse-Phase
1
2016
28
0.030
 Why?
Breast Feeding
1
2020
439
0.030
 Why?
Patient Selection
1
2020
689
0.030
 Why?
Drug Storage
1
2016
57
0.030
 Why?
Defective Viruses
1
2016
5
0.030
 Why?
Cities
1
2017
131
0.030
 Why?
Acute Disease
1
2019
1006
0.030
 Why?
Drug Compounding
1
2016
97
0.030
 Why?
Solubility
1
2016
247
0.030
 Why?
Alcohol Drinking
1
2023
818
0.030
 Why?
Methanol
1
2016
38
0.030
 Why?
Spermatozoa
1
2016
94
0.030
 Why?
Clinical Trials as Topic
1
2020
1043
0.030
 Why?
Solutions
1
2016
169
0.030
 Why?
Cold Temperature
1
2016
177
0.030
 Why?
Hydrogen-Ion Concentration
1
2016
564
0.030
 Why?
Blood-Brain Barrier
1
2016
140
0.030
 Why?
Administration, Inhalation
1
2016
683
0.030
 Why?
Pregnancy Complications
1
2020
522
0.030
 Why?
Comorbidity
1
2019
1611
0.030
 Why?
Risk-Taking
1
2017
348
0.030
 Why?
Logistic Models
1
2020
2060
0.030
 Why?
Interleukins
1
2016
251
0.030
 Why?
DNA, Viral
1
2016
362
0.030
 Why?
Vitamin D-Binding Protein
1
2013
15
0.030
 Why?
Recurrence
1
2017
1058
0.030
 Why?
Feasibility Studies
1
2017
947
0.030
 Why?
Mental Health
1
2019
721
0.030
 Why?
Parathyroid Hormone
1
2013
108
0.030
 Why?
Algorithms
1
2020
1686
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
251
0.020
 Why?
Water
1
2016
463
0.020
 Why?
Therapeutic Equivalency
1
2012
32
0.020
 Why?
Alkynes
1
2012
56
0.020
 Why?
Cell Line
1
2017
2836
0.020
 Why?
Anion Exchange Resins
1
2011
8
0.020
 Why?
Zidovudine
1
2011
78
0.020
 Why?
Food-Drug Interactions
1
2010
9
0.020
 Why?
Reference Standards
1
2011
183
0.020
 Why?
Longitudinal Studies
1
2018
2847
0.020
 Why?
Chemoprevention
1
2010
92
0.020
 Why?
Latent Tuberculosis
1
2011
69
0.020
 Why?
Epithelial Cells
1
2016
1093
0.020
 Why?
Haplotypes
1
2011
490
0.020
 Why?
Cholesterol
1
2011
410
0.020
 Why?
Glomerular Filtration Rate
1
2013
744
0.020
 Why?
Triglycerides
1
2011
524
0.020
 Why?
AIDS Dementia Complex
1
2009
51
0.020
 Why?
Infant, Newborn
1
2020
6046
0.020
 Why?
Polymorphism, Genetic
1
2011
657
0.020
 Why?
Follow-Up Studies
1
2017
5115
0.020
 Why?
Cross-Sectional Studies
1
2019
5417
0.020
 Why?
Acquired Immunodeficiency Syndrome
1
2009
232
0.020
 Why?
Positron-Emission Tomography
1
2009
295
0.020
 Why?
Antiemetics
1
1987
43
0.020
 Why?
Calcium
1
2013
1197
0.020
 Why?
Vomiting
1
1987
129
0.020
 Why?
Gene Expression Regulation
1
2016
2603
0.020
 Why?
Aged, 80 and over
1
2018
7569
0.020
 Why?
Neuropsychological Tests
1
2009
1054
0.010
 Why?
Brain
1
2016
2669
0.010
 Why?
Age Factors
1
2011
3290
0.010
 Why?
Alzheimer Disease
1
2009
557
0.010
 Why?
Magnetic Resonance Imaging
1
2009
3566
0.010
 Why?
Antineoplastic Agents
1
1987
2129
0.010
 Why?
Flunitrazepam
1
1987
3
0.000
 Why?
Metoclopramide
1
1987
19
0.000
 Why?
Methylprednisolone
1
1987
85
0.000
 Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (358) concept(s)
_
Co-Authors Expand Description
See all (30) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)